INTRODUCTION

C
hronic Fatigue Syndrome (CFS) is a debilitating syndrome characterized by fatigue which, by exclusion, cannot be ascribed to another illness. Because of the vagueness of the symptoms and signs in patients with CFS, various attempts have been made to define the syndrome and classification criteria have been developed (1) (2) (3) , of which the most well-known and used are those of Fukuda et al. (1) This classification includes two major criteria: 1) the presence of new persisting, debilitating fatigue that does not resolve with bed rest, reduces daily activities by at least 50% and lasts for at least six months; 2) the exclusion of any other known disease which can cause fatigue; and at least eight of eleven minor criteria (low-grade fever, shivers, pharyngitis, cervical or axillary lymphnodes, myal- function and make the host more vulnerable to an infection. The aim of this study was to gather the demographic and clinical characteristics of a group of Italian patients with certified Chronic Fatigue Syndrome (CFS) through an observational study and compare these data with the updated, available international literature on the subject. Secondary objectives were to collect information on laboratory and image testing in order to exclude an alternative diagnosis and to try to outline a pattern of symptoms that can better define the syndrome with the etiological hypotheses in mind.
PATIENTS AND METHODS
Patients were recruited through the Italian referral centers for CFS (Centro di Riferimento Oncologico of Aviano, Prof. U. Tirelli, and the Dept. of Infectious Diseases, University of Chieti, Prof. G. Pizzigallo).
Patients who also had a diagnosis of fibromyalgia, irritable bowel syndrome or other non-invalidating chronic pathologies (allergies or hypertension) were not excluded from the study. A questionnaire was developed to investigate the demographic and clinical characteristics of the participants, including age, sex, education and profession, timing and nature of the onset of symptoms, persistence of symptoms (fatigue, pain, weakness, cognitive impairment, fever, arthralgia/myalgias, depression), duration of illness, and criteria used to diagnose CFS. Room was left for patients to write other symptoms. Laboratory and image testing were also investigated, as were viral serology, personal and family histories for autoimmune/allergic diseases, CFS, genetic diseases, and prescribed therapy. One-hundred and nineteen patients were contacted by phone to participate in the study. To the 81 patients who agreed the questionnaire was sent home. The study was part of the development of a blood bank at the University of Pavia (laboratory of Immunogenetics, Department of Genetics and Microbiology, Prof. M. Cuccia) and the patients arrived on the day of blood withdrawal with the questionnaire completed. Any omittance was completed with documentation provided by the patients and controlled by the author. Informed written consent was obtained from all of the participants; this study was approved by the ethics committee of the University of Pavia.
RESULTS
Demographic aspects
81 patients completed the questionnaire and returned it. The demographic characteristics are summarized in Table I . We observed a bias towards female sex (3:1 ratio) in agreement with international literature (7) (8) (9) (10) (11) . Patients' occupation is evenly distributed and dominated by employees and housewives, whereas teachers and healthcare professionals come in third position.
Clinical characteristics
Patients age is mostly comprised between 18 and 50 years, and many patients have been suffering from CFS from a long period of time (mean 8.9 years) ( Table I ). We can infer that the patient population is in the chronic state of the disease with relapses and periods of well-being. The onset of symptoms is freely described by patients in the questionnaire. We observed that the infectious (Herpes viruses), neurological (CRH-ACTH-cortisol axis) and immune hypotheses of the syndrome are well reflected by the descriptions of the onset of CFS (Table II) . In fact, the flu-like (Table III) constantly include fatigue (92.6%), post-exertional malaise (91.4%) and pain (87.6%). These are general symptoms that are often encountered in systemic diseases. However, patients also describe arthralgia/myalgia (89%), neurological symptoms (especially lack of concentration in 86.4% of patients), and low-grade fever (63%), as persisting symptoms. These observations are helpful in order to better outline the characteristics of the syndrome, although none are pathognomonic.
The accompanying symptoms present in these patients underline the heterogeneity of CFS. We observed a predominance of neurological and psychiatric symptoms (including unrefreshing sleep (16%), anxiety (3.7%), transitory paresis (3.7%), the afore-mentioned cognitive symptoms(26%), and headaches (13.6%), irritable bowel syndrome (9.9%), arthralgia/myalgias (11.1%), swollen lymphnodes (11%), and dyspnea (7.4%). The validity of the Fukuda criteria is underscored by laboratory and image tests. These patients have undergone a wide variety of tests that result in the normalcy (73% of patients) of most parameters studied. The alterations noted (herniated disks in 12.3% of patients, 1 patient with Milwaukee shoulder, 2 with carpal tunnel syndrome, 1 patient with a reactive lymphnode) are frequent in the general population and unlikely to influence a diagnosis of CFS. The viral serology studied in many patients shows evidence of exposure to EBV (45.7%), a characteristic that has already been described (Holmes et al.
International literature generally confirms these data and also includes exposure to CMV (9.9% in our study), HHV6 (6.2% in our patients), Enteroviruses (3.7%) and parvovirus B19 as possible causative agents (13, 14) . If this study has begun to delineate some observations on the clinical characteristics of patients with CFS, the same cannot be said for therapy prescribed to patients, which is heterogeneous and of little benefit (Table IV) . There is little compliance towards physiotherapy and cognitive-behavioral therapy (CBT) proposed by international literature (17) . It has mostly encountered patients' resistence when proposed, but systematic studies are lacking in Italy.
Patients' history has shown that CFS does not seem to be inheritable in a Mendelian manner (CFS is ab- sent in 95.1% of patients' families, and present in 2.5%; undetermined: 2.5%). We did not have monzigotic or dizogotic twins among the patient cohort, nor does the syndrome seem to be transmitted in families. However, we observed many allergies or autoimmune diseases both in the patient (38.3% and 13.5% respectively) or in their family (22.2% and 28.4% respectively). These data compelled us to pursue the study of certain genes in the immune system as being possibly involved in CFS.
DISCUSSION
The epidemiology of CFS has been studied in the United States where the estimated prevalence was found to be 0.42% (7), Asia (9), Australia (8) and some European countries (11, 12, 16) (Fig. 1) . Most countries where the epidemiology has been studied have an approximately similar estimate with the exception of Sweden (2.36%) and Australia (0.037%). The literature is discordant on the subject of social class: some studies have indicated an increased presence of teachers and healthcare professionals (11) but we have found evidence of an equal distribution among the working classes in accordance with more recent literature (12) , and all social classes seem to be affected. In Italy, estimates of the prevalence and incidence of the syndrome are unavailable. Two studies have been published in Italy concerning the epidemiology of CFS. The first, published in 1994 (10), studied the prevalence of CFS in patients with fatigue who were sent to a secondary referral center in Internal Medicine (127 patients). Of these, 30% did not fulfill the second major criterium (another disease was identified as cause of fatigue) or did not fulfill all of the inclusion criteria. 28.5% remained without a definitive diagnosis, 59% had another diagnosis (of a psychiatric nature), and 9.5% of the patients that completed the study (6/63) were diagnosed with Chronic Fatigue Syndrome. The second study, published in 1999 (15) compared the two existing case definitions of CFS: (Holmes and Fukuda) patients with persistent fatigue were screened with a questionnaire, lab testing and a psychiatric interview. The authors concluded that patients fulfilling the Fukuda criteria were more likely to be male, of upper social class, married, and less likely to have had an acute onset (with symptoms and signs of a flu-like disease) with respect to the patients fulfilling the Holmes criteria. This study has outlined a syndrome which can be considered a disease entity characterized by fatigue, infectious, neurological and rheumatological symptoms. These characteristics are present at the onset of the illness and tend to persist over time. Thus a dysregulation of psychosomatic nature cannot be ruled out as the primum movens of CFS. In fact a Japanese study on the SNPs of the promoter of the serotonin receptor gene supports this hypothesis (6).
The Italian patient population studied has demographic aspects in accordance with international literature. Precise epidemiological data are lacking in Italy, as are studies on the effectiveness of therapy prescribed by the referral centers for CFS.
